Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
A new drug, 2-HDP, shows promise in preventing diabetes-related vision loss by protecting retinal cells in diabetic rats and humans.
A new drug called 2-HDP shows promise in preventing vision loss in people with diabetes, according to a study led by Queen’s University Belfast and funded by Diabetes UK.
The treatment protected retinal cells and blood vessels in diabetic rats, reduced inflammation, and preserved vision by neutralizing harmful molecules that build up in the retina due to high blood sugar.
Researchers detected these same toxic molecules in human retinal tissue from people with diabetes, suggesting the drug could be effective in humans.
Computer simulations indicate it may be developed into an oral tablet.
The findings, published in Diabetologia, highlight the potential for early intervention to stop irreversible damage, offering hope for a new generation of treatments that could preserve vision for millions.
Un nuevo medicamento, 2-HDP, se muestra prometedor para prevenir la pérdida de visión relacionada con la diabetes al proteger las células de la retina en ratas y humanos diabéticos.